An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01142869
Recruitment Status : Terminated (The study was discontinued due to slow recruitment and subjects not completing follow up period.)
First Posted : June 11, 2010
Last Update Posted : May 8, 2017
Merck Ltd., India
Information provided by (Responsible Party):
Merck KGaA

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 31, 2013
  Actual Study Completion Date : August 5, 2014